Fig. 2

Nicotinic receptor subunit gene expression. Box plots show fold change (2^−ΔΔCt) expression through qRT-PCR in DLB and AD patients, respect to the group of HC. a nAChRα7 gene expression, SW test value = 0.86, p = 0.007; *p-value derived from Mann-Whitney U test AD vs DLB p = 0.454; §p-value derived from Sign test DLB vs HC p = 0.002; §p-value derived from Sign test AD vs HC p = 0.021. b nAChRα3 gene expression, SW test value = 0.72, p < 0.0001; *p-value derived from Mann-Whitney U test AD vs DLB p < 0.001; §p-value derived from Sign test DLB vs HC p = 0.030; §p-value derived from Sign test AD vs HC p = 0.039. c nAChRα4 gene expression, SW test value = 0.71, p < 0.0001; *p-value derived from Mann-Whitney U test AD vs DLB p < 0.001; §p-value derived from Sign test DLB vs HC p = 0.011; §p-value derived from Sign test AD vs HC p = 0.002. d nAChRβ4 gene expression, SW test value = 0.66, p < 0.0001; *p-value derived from Mann-Whitney U test AD vs DLB p < 0.001; §p-value derived from Sign test DLB vs HC p = 0.012; §p-value derived from Sign test AD vs HC p = 0.001. e nAChRβ2 gene expression, SW test value = 0.90 p = 0.014. *p-value derived from Mann-Whitney U test AD vs DLB p < 0.001; §p-value derived from Sign test DLB vs HC p < 0.001; §p-value derived from Sign test AD vs HC p = 0.011